Loading
OS
OSX Stock: price and insider trades · Australia
OSX: what insiders have been doing
This page follows insider dealings at OSX as filed with ASX, a company from the Health Care sector. Between 18 October 2025 and 18 October 2026, 1 insider published 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Over the last twelve months, not one insider purchase of OSX stock was filed.
With 2 filings in twelve months, the company is quieter than the median of 3 filings across the 2,530 companies we follow on the same exchange.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Anixa Biosciences Inc. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
A$0.00
Analyst consensus
Income statement
RevenueA$3.1M
Gross profitA$2.4M78% margin
EBITDA-A$2.9M-95% margin
Net income-A$3.7M-121.8% margin
Valuation
Beta-0.02
Balance sheet & cash
Market capA$2.8M
Total debtA$2.8M
Free Cash Flow-A$2.6M
Profitability & ownership
ROA-70.3%
% insiders18.3%
% institutions4.4%
Last declaration on 4 May 2026
About OSX
OSX is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
